Agendia Raises Double Digit $ Millions in Series A Round for Microarray-Based Cancer Tests | GenomeWeb

This story has been updated from an earlier version to include more precise funding information from Agendia.


NEW YORK, GenomeWeb News (March 30) - Dutch cancer diagnostics company Agendia has raised "double digit" millions of dollars in a Series A financing round, the company told GenomeWeb News today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.